These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23325065)

  • 1. Efficacy and safety of liposomal amphotericin B for deep mycosis in patients with connective tissue disease.
    Kotani T; Takeuchi T; Makino S; Hata K; Yoshida S; Nagai K; Wakura D; Isoda K; Hanafusa T
    J Infect Chemother; 2013 Aug; 19(4):691-7. PubMed ID: 23325065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the safety and efficacy of liposomal amphotericin B (L-AMB) in children.
    Sunakawa K; Tsukimoto I; Tsunematsu Y; Honda M; Iwai N; Maniwa T; Haigo H; Suzuki K; Mori T
    J Infect Chemother; 2012 Aug; 18(4):456-65. PubMed ID: 22286407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evaluation of frequency of nephrotoxicity caused by liposomal amphotericin B.
    Kato H; Hagihara M; Yamagishi Y; Shibata Y; Kato Y; Furui T; Watanabe H; Asai N; Koizumi Y; Mikamo H
    J Infect Chemother; 2018 Sep; 24(9):725-728. PubMed ID: 29773439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retrospective investigation on the cases treated with liposomal amphotericin B].
    Yamagishi Y; Mikamo H
    Jpn J Antibiot; 2010 Oct; 63(5):347-64. PubMed ID: 21268407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Low-Dose Liposomal Amphotericin B in Adult Patients Undergoing Unrelated Cord Blood Transplantation.
    Yasu T; Konuma T; Oiwa-Monna M; Kato S; Tanoue S; Isobe M; Mizusawa M; Kuroda S; Takahashi S; Tojo A
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study.
    Chamilos G; Luna M; Lewis RE; Chemaly R; Raad II; Kontoyiannis DP
    Clin Ther; 2007 Sep; 29(9):1980-6. PubMed ID: 18035197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of liposomal amphotericin B on renal function in critically ill patients with renal function impairment.
    Alvarez-Lerma F; Soriano MC; Rodríguez M; Catalán M; Llorente AM; Vidart N; Garitacelaya M; Maraví E; Fernández E; Alvarado F; López M; Alvarez-Sánchez B; Espinosa J; Quintana E;
    Rev Esp Quimioter; 2012 Sep; 25(3):206-15. PubMed ID: 22987267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study.
    Morello E; Pagani L; Coser P; Cavattoni I; Cortelazzo S; Casini M; Billio A; Rossi G
    Bone Marrow Transplant; 2011 Jan; 46(1):132-6. PubMed ID: 20383205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence and improvement of renal dysfunction and serum potassium abnormality during administration of liposomal amphotericin B in patients with hematological disorders: A retrospective analysis.
    Yamazaki H; Kondo T; Aoki K; Yamashita K; Takaori-Kondo A
    Diagn Microbiol Infect Dis; 2018 Feb; 90(2):123-131. PubMed ID: 29203252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuously infused amphotericin B deoxycholate for primary treatment of invasive fungal disease in acute myeloid leukaemia.
    Rothenbühler C; Held U; Manz MG; Schanz U; Gerber B
    Hematol Oncol; 2018 Apr; 36(2):471-480. PubMed ID: 29431860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients.
    Prentice HG; Hann IM; Herbrecht R; Aoun M; Kvaloy S; Catovsky D; Pinkerton CR; Schey SA; Jacobs F; Oakhill A; Stevens RF; Darbyshire PJ; Gibson BE
    Br J Haematol; 1997 Sep; 98(3):711-8. PubMed ID: 9332329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphotericin B deoxycholate (d-AMB) use in cases with febrile neutropenia and fungal infections: lower toxicity with suitable premedication.
    Oto OA; Paydas S; Disel U; Yavuz S; Seydaoglu G
    Mycoses; 2007 Mar; 50(2):135-9. PubMed ID: 17305778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of treatment with liposomal amphotericin B in elderly patients at least 65 years old with hematological diseases.
    Ueda S; Miyamoto S; Kaida K; Chizuka A; Kojima R; Takano J; Ogasawara T; Miyamoto K; Miyakoshi S; Kanda Y
    J Infect Chemother; 2016 May; 22(5):287-91. PubMed ID: 26908230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Usefulness of Early Potassium Supplementation for Preventing Severe Hypokalemia Induced by Liposomal Amphotericin B in Hematologic Patients: A Retrospective Study.
    Okada N; Azuma M; Imanishi M; Zamami Y; Kirino Y; Nakamura T; Teraoka K; Abe M; Ishizawa K
    Clin Ther; 2018 Feb; 40(2):252-260. PubMed ID: 29305017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor analysis of acute kidney injury in patients administered liposomal amphotericin B in a real-world clinical setting in Japan.
    Takazono T; Tashiro M; Ota Y; Obata Y; Wakamura T; Miyazaki T; Nishino T; Izumikawa K
    Sci Rep; 2020 Sep; 10(1):15033. PubMed ID: 32929112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How low can you go? Use of low- and standard-dose liposomal amphotericin B for treatment of invasive fungal infections.
    Kassamali Z; Danziger LH; Glowacki RC; Schwartz DN
    Int J Infect Dis; 2013 Aug; 17(8):e615-20. PubMed ID: 23474174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Budget impact analysis of liposomal amphotericin B and amphotericin B lipid complex in the treatment of invasive fungal infections in the United States.
    Yang H; Chaudhari P; Zhou ZY; Wu EQ; Patel C; Horn DL
    Appl Health Econ Health Policy; 2014 Feb; 12(1):85-93. PubMed ID: 24385260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with liposomal Amphotericin-B in 60 patients undergoing high-dose therapy and bone marrow or peripheral blood stem cell transplantation.
    Krüger W; Stockschläder M; Rüssmann B; Berger C; Hoffknecht M; Sobottka I; Kohlschütter B; Kroschke G; Kröger N; Horstmann M
    Br J Haematol; 1995 Nov; 91(3):684-90. PubMed ID: 8555076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective phase II single-center study of the safety of a single very high dose of liposomal amphotericin B for antifungal prophylaxis in patients with acute myeloid leukemia.
    Annino L; Chierichini A; Anaclerico B; Finolezzi E; Norata M; Cortese S; Cassetta MI; Fallani S; Novelli A; Girmenia C
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2596-602. PubMed ID: 23529741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Liposomal-amphotericin B efficacy and safety].
    Hamada Y; Komatsu T; Seto Y; Matsubara H; Kume H; Sunakawa K; Yago K
    Kansenshogaku Zasshi; 2010 Mar; 84(2):193-8. PubMed ID: 20420165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.